GNAO1 mutation-related involuntary movements and rhabdomyolysis: A case report


Çiçek S., Yıldırım M., Bektaş Ö., Kartal A. T., Teber S.

15th Congress of the European Paediatric Neurology Society (EPNS), Praha, Çek Cumhuriyeti, 20 - 24 Haziran 2023, ss.435

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: Praha
  • Basıldığı Ülke: Çek Cumhuriyeti
  • Sayfa Sayıları: ss.435
  • Ankara Üniversitesi Adresli: Evet

Özet

 Objective: Mutations in GNAO1 typically result in neurodevelopmental disorders such as developmental and epileptic encephalopathy-17, and involuntary movements. To date, the association of variants in the GNAO1 gene with rhabdomyolysis has been identified in few patients. We present a 2-year-old girl with a GNAO1 gene mutation who developed rhabdomyolysis. Case presentation: A 2-year-old girl presented with fever, choreoathetosis and inability to eat for two days. She had a history of hypotonia, global developmental delay, and hyperkinetic involuntary movements, including choreoathetosis. Abnormal involuntary movements were exacerbated by illness and fever. She was born after uneventful pregnancy and delivery, with a non-consanguineous marriage of her parents. She had no family history for neuromuscular disease. Laboratory tests showed high serum creatine kinase level, transaminase and lactate dehydrogenase levels, myoglobinuria and normal renal function tests. Brain MRI showed mild cerebral atrophy. Electroencephalography (EEG) revealed no pathological findings. The whole exome sequencing test showed a novel de novo heterozygous variant of GNAO1 gene [c.736G>A; (p.Glu246Lys)], located on chromosome 16q13. The mutation was confirmed by Sanger sequencing. Based on these clinical and laboratory finding, she was diagnosed rhabdomyolysis related to neurodevelopmental disorder with involuntary movements associated with GNAO1 mutation. Initial creatine kinase (CK) level was 76350 U/L. On the third day of hospitalization, creatine kinase level increased to 107000 U/L. She was treated with excessively intravenous isotonic fluids containing sodium bicarbonate. On the sixth day of hospitalization, serum creatine levels and choreoathetosis improved significantly. Conclusion: Our case demonstrated that GNAO1 variants can cause severe developmental delay and refractory hyperkinetic involuntary movements caused rhabdomyolysis. We suggest caution in terms of rhabdomyolysis when hyperkinetic movements develop in patients with GNAO1 mutation.